Analysis of the Receptor Activator of NF-?B Ligand/Osteoprotegerin (RANKL/OPG) ratio as potential biomarker for infection-related bone destruction in pyogenic vertebral osteomyelitis

Benzer Materyaller

• Analysis of the Receptor Activator of NF-?B Ligand/Osteoprotegerin (RANKL/OPG) ratio as potential biomarker for infection-related bone destruction in pyogenic vertebral osteomyelitis
  Yazar:: S. Lang, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-01-01)
• Vertebral osteomyelitis is characterised by increased RANK/OPG and RANKL/OPG expression ratios in vertebral bodies and intervertebral discs
  Yazar:: S Lang, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-11-01)
• Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
  Yazar:: Siamak Kazemi-Sufi, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-09-01)
• Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
  Yazar:: Riham Eid, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-06-01)
• Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway
  Yazar:: Xiao-Feng He, ve diğerleri
  Baskı/Yayın Bilgisi: (2017-11-01)